                </a></li></ul></div><p><strong>Figure 6.  <span>EGFP immunoreactivity following subretinal injection.</span></strong></p><a id="article1.body1.sec3.fig6.caption1.p1" name="article1.body1.sec3.fig6.caption1.p1"></a><p>To eliminate any artifacts due to retinal autofluorescence, immunohistochemistry was performed with a Cy-3-anti-GFP antibody on paraffin-embedded ocular sections from eyes taken at 2-days post-injection of 0.6 µg of compacted DNA.</p>
<a id="article1.body1.sec3.fig6.caption1.p2" name="article1.body1.sec3.fig6.caption1.p2"></a><p>An absence of or minimal EGFP immunoreactivity was found in the mock-injected and naked plasmid-injected eyes, respectively.</p>
<a id="article1.body1.sec3.fig6.caption1.p3" name="article1.body1.sec3.fig6.caption1.p3"></a><p>Examination of sections from eyes injected with the AC-GFP nanoparticle revealed high-level EGFP immunoreactivity in nearly all of the cells in the ONL.</p>
<a id="article1.body1.sec3.fig6.caption1.p4" name="article1.body1.sec3.fig6.caption1.p4"></a><p>Lower levels of EGFP were also detected within the upper half of the INL.</p>
<a id="article1.body1.sec3.fig6.caption1.p5" name="article1.body1.sec3.fig6.caption1.p5"></a><p>Scale bar, 10 µM.</p>
<span>THISISTHEEND
